About the Authors
- Kengo Suzuki
-
Roles Supervision, Writing – original draft
Affiliation Euglena Co., Ltd., Shiba, Minato-ku, Tokyo, Japan
- Ayaka Nakashima
-
Roles Investigation, Project administration, Writing – original draft
Affiliation Euglena Co., Ltd., Shiba, Minato-ku, Tokyo, Japan
- Masaharu Igarashi
-
Roles Formal analysis
Affiliation New Drug Research Center, Inc., Toiso, Eniwa, Hokkaido, Japan
- Keita Saito
-
Roles Formal analysis, Writing – original draft
Affiliation New Drug Research Center, Inc., Toiso, Eniwa, Hokkaido, Japan
- Makoto Konno
-
Roles Investigation, Writing – original draft
Affiliation New Drug Research Center, Inc., Toiso, Eniwa, Hokkaido, Japan
- Noriyuki Yamazaki
-
Roles Investigation, Writing – original draft
Affiliation New Drug Research Center, Inc., Toiso, Eniwa, Hokkaido, Japan
- Hiroaki Takimoto
-
Roles Supervision
* E-mail: takimoto@sci.kitasato-u.ac.jp
Affiliation Kitasato University, School of Science, Department of Biosciences, Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan
Competing Interests
Dr. Kengo Suzuki and Ms. Ayaka Nakashima are employees of euglena Co., Ltd., and Mr. Masaharu Igarashi, Mr. Keitai Saito, Mr. Makoto Konno and Mr. Noriyuki Yamazaki are employees of New Drug Research Center, Inc. The results presented in this manuscript are patent pending in Japan. There are no other patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.